During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
Sinkhole causes two lanes to collapse but luckily no injuries have been reported.
A freezer full of crocodile heads was found rotting and half-thawed in Australia's Northern Territory, police have said.
Typhoon Soudelor is expected to make land fall on Friday, hitting Taiwan and then eastern China.